Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis

According to WHO report, globally about 10 million active tuberculosis cases, resulting in about 1.6 million deaths, further aggravated by drug-resistant tuberculosis and/or comorbidities with HIV and diabetes are present. Incomplete therapeutic regimen, meager dosing, and the capability of the late...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Saad, Rehman, Shaheed Ur, Shesha, Nashwa Talaat, Faidah, Hani, Khurram, Muhammad, Rehman, Sabi Ur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729780/
https://www.ncbi.nlm.nih.gov/pubmed/33276545
http://dx.doi.org/10.3390/molecules25235685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729780/
https://www.ncbi.nlm.nih.gov/pubmed/33276545
http://dx.doi.org/10.3390/molecules25235685

Ejemplares similares